Effectiveness of Chiropractic Application for Acute Low Back Pain
NCT ID: NCT04110119
Last Updated: 2021-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
98 participants
INTERVENTIONAL
2018-10-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing the Effect of Chiropractic Manipulation and Spinal Decompression Device Treatment
NCT05460286
Investigation of the Effect of Motor Imagery Training in Individuals with Cervical Discogenic Pain
NCT05999565
The Effectiveness of Manipulation Treatment in Cervical Region
NCT04455048
Spinal Manipulation Effectiveness in Spinal Disorders
NCT03190187
Evaluation of The Immediate Effect of Myofascial Release Application in Patients With Chronic Low Back Pain
NCT05302882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control: Drug-Only Group
Patients with acute lower-back pain who have undergone routine conventional drug treatment at the first visit to the emergency department (49 patients). The drug treatment consists of analgesic-anti-inflammatory (diclophenac sodium 75 mg IM) and myorelaxant (thiocolchicoside 4 mg IM), administered only once.
diclophenac sodium (75 mg, IM) and thiocolchicoside (4 mg, IM)
Single intramuscular injection of mixture of two commercial drugs (Analgesic-anti-inflammatory and myorelaxant) at the specified dosages
Case: Drug and Chiropractic Group
Patients, who received chiropractic treatment immediately after the conventional drug treatment as in the control group (49 patients). The chiropractic treatment consists of high speed and low amplitude spinal manipulation techniques, applied only once.
diclophenac sodium (75 mg, IM) and thiocolchicoside (4 mg, IM)
Single intramuscular injection of mixture of two commercial drugs (Analgesic-anti-inflammatory and myorelaxant) at the specified dosages
Chiropractic Treatment
High speed and low amplitude spinal manipulation techniques are applied to the case group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diclophenac sodium (75 mg, IM) and thiocolchicoside (4 mg, IM)
Single intramuscular injection of mixture of two commercial drugs (Analgesic-anti-inflammatory and myorelaxant) at the specified dosages
Chiropractic Treatment
High speed and low amplitude spinal manipulation techniques are applied to the case group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute lower-back pain, persisting less than 6 weeks, meeting the diagnostic classification of 1 or 2 according to the Quebec Task Force on Spinal Disorders
Exclusion Criteria
* Spinal nerve root irritation or deficits,
* Pregnant women,
* Lower-back pain due to occupational accidents
* Obesity status (body mass index\> 30).
* Chronic lower-back pain longer than 6 weeks.
19 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ALI TIMUCIN ATAYOGLU
Assistant Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medipol University
Beykoz, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMUEC441
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.